
Medpace Holdings MEDP
€ 527.95
-0.73%
Medpace Holdings Betriebsaufwand | MEDP
Betriebsaufwand Jährlich Medpace Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 118 M | 114 M | 110 M | 120 M | 127 M | - | 65.6 M | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 127 M | 65.6 M | 109 M |
Betriebsaufwand anderer Aktien in der Diagnostik & Forschung
| Name | Betriebsaufwand | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
47.4 M | - | -8.98 % | $ 14.8 K | ||
|
Heska Corporation
HSKA
|
131 M | - | - | $ 1.31 B | ||
|
DermTech
DMTK
|
104 M | - | -11.32 % | $ 2.94 M | ||
|
Centogene N.V.
CNTG
|
58 M | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
778 M | - | -17.87 % | $ 25.9 M | ||
|
Celcuity
CELC
|
172 M | $ 82.62 | -6.47 % | $ 3.86 B | ||
|
Mettler-Toledo International
MTD
|
1.01 B | $ 1 327.18 | -0.15 % | $ 27.4 B | ||
|
Myriad Genetics
MYGN
|
964 M | $ 5.61 | -1.58 % | $ 519 M | ||
|
Aspira Women's Health
AWH
|
13.8 M | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
77.2 M | - | -61.36 % | $ 2.46 M | ||
|
NeoGenomics
NEO
|
430 M | $ 13.89 | -2.46 % | $ 1.78 B | ||
|
Neogen Corporation
NEOG
|
1.48 B | $ 9.4 | -2.19 % | $ 2.04 B | ||
|
Natera
NTRA
|
258 M | $ 261.99 | -1.02 % | $ 35.8 B | ||
|
Biocept
BIOC
|
21.6 M | - | -13.05 % | $ 7.29 M | ||
|
OPKO Health
OPK
|
217 M | $ 1.22 | 4.27 % | $ 847 M | ||
|
Pacific Biosciences of California
PACB
|
600 M | $ 1.36 | -2.86 % | $ 408 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
59.4 M | - | - | $ 562 M | ||
|
Co-Diagnostics
CODX
|
50.6 M | $ 2.1 | -4.98 % | $ 2.79 M | ||
|
Chembio Diagnostics
CEMI
|
28.5 M | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
14.1 M | - | - | $ 9.42 M | ||
|
HTG Molecular Diagnostics
HTGM
|
24.1 M | - | -20.0 % | $ 1.06 M | ||
|
Quidel Corporation
QDEL
|
285 M | $ 16.05 | -3.2 % | $ 676 M | ||
|
Global Cord Blood Corporation
CO
|
451 M | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
134 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
5.91 M | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
983 M | - | 0.12 % | $ 80.1 M | ||
|
Neuronetics
STIM
|
104 M | $ 1.73 | -7.98 % | $ 114 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
585 M | - | - | $ 10.7 B | ||
|
Trinity Biotech plc
TRIB
|
28.3 M | $ 8.45 | -5.73 % | $ 3.04 B | ||
|
Twist Bioscience Corporation
TWST
|
116 M | $ 90.27 | -2.35 % | $ 5.4 B | ||
|
Exact Sciences Corporation
EXAS
|
2.47 B | - | - | $ 19.8 B | ||
|
CareDx, Inc
CDNA
|
411 M | $ 37.14 | -1.25 % | $ 1.98 B | ||
|
QIAGEN N.V.
QGEN
|
821 M | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
181 M | - | - | $ 2.69 B | ||
|
DarioHealth Corp.
DRIO
|
49.3 M | $ 7.79 | 4.28 % | $ 31 M | ||
|
Quest Diagnostics Incorporated
DGX
|
1.46 B | $ 227.86 | -0.02 % | $ 25.3 B | ||
|
Motus GI Holdings
MOTS
|
19.1 M | - | -34.28 % | $ 263 K | ||
|
Biomerica
BMRA
|
5.64 M | $ 1.59 | -0.94 % | $ 3.65 M | ||
|
Invitae Corporation
NVTA
|
343 M | - | - | $ 21.2 M | ||
|
Organovo Holdings
ONVO
|
23.3 M | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
21.9 M | - | -16.95 % | $ 1.54 M | ||
|
Anixa Biosciences
ANIX
|
9.98 M | $ 3.7 | -1.33 % | $ 120 K | ||
|
PerkinElmer
PKI
|
1.07 B | - | -0.91 % | $ 14.7 B | ||
|
DexCom
DXCM
|
1.89 B | $ 71.54 | 1.5 % | $ 27.9 B | ||
|
Psychemedics Corporation
PMD
|
8.99 M | - | -1.84 % | $ 15.3 M | ||
|
ICON Public Limited Company
ICLR
|
408 M | $ 165.76 | -2.68 % | $ 13 B | ||
|
Quotient Limited
QTNT
|
119 M | - | -11.32 % | $ 1.1 M | ||
|
T2 Biosystems
TTOO
|
38.2 M | - | -39.35 % | $ 313 K | ||
|
Renalytix AI plc
RNLX
|
29.8 M | - | 5.66 % | $ 22.7 M |